Skip to main content

Home/ Cerebral Palsy/ Group items tagged movement disorders treatments

Rss Feed Group items tagged

Lee Vander Loop

Botulinum Toxin (BOTOX) for Cerebral Palsy - 0 views

  •  
    Clinical trial being conducted by Eunice Kennedy Shriver NationalInstitute of Child Health and Human Development NICHD to examine botulinum toxin (BOTOX, or BTX) for the treatment of muscle twitches and spasticity associated with cerebral palsy in children. Botulinum toxin is a naturally occurring bacterial toxin (botulinum toxin) that inactivates certain parts of muscles.
Lee Vander Loop

Dystonia - Description - 0 views

  •  
    Dystonia at Movement Disorder Virtual University Resource Library - Classifications of Dystonia - Causes- Treatment and Medications - Surgical Treatments - References
Lee Vander Loop

Hypotonia Information Page: National Institute of Neurological Disorders and Stroke (NI... - 0 views

  •  
    Hypotonia Information at NINDS - Includes description - treatment options - prognosis - research - clinical trials and organizations
Lee Vander Loop

Pilot Efficacy Study of T2000 in Myoclonus Dystonia - 0 views

  •  
    Effect of treatment on the movement disorder will be measured by a myoclonus scale and a dystonia scale as well as by assessment of overall functional status. Response at various dosages will be compared to baseline for all patients.Safety parameters including neurological examination, blood tests and EKG will be monitored throughout the treatment period and during withdrawal of the medication.
Lee Vander Loop

Botulinum Toxin for the Treatment of Involuntary Movement Disorders - 0 views

  •  
    Study will examine the effectiveness of botulinum toxin as treatment for a variety of movement disorders. The goals of the study are to refine the technique of treatment to provide the best results, to improve the understanding of how botulinum toxin works on movement disorders, and find other conditions that may be treatable with botulinum toxin.In addition, researchers also plan to study the possible use of botulinum toxin F alone and in combination with botulinum toxin A in patients who do not respond to botulinum A toxin treatment.
Lee Vander Loop

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects - 0 views

  •  
    Stanford University sponsored study of trihexyphenidyl in children with upper extremity dystonia due to cerebral palsy. It is hypothesized that trihexyphenidyl in doses up to 0.75mg/kg/day would be well-tolerated and show significant changes on the Melbourne scale of upper extremity function.
1 - 6 of 6
Showing 20 items per page